IL37 and cancer: Due to its potent effect for inhibiting innate and adaptive immune responses, our recent publication revealed that IL-37 was also closely associated with cancer development such as oral squamous cell carcinoma, colorectal cancer, and hepatocellular carcinoma (14–16).